The webinar on September 16, 2025, focuses on the ethics and challenges of a clinical trial for puberty blockers in children referred to youth gender clinics. Experts will discuss ideas about alternative research methods that could better improve care for children and young people with gender related distress.| Clinical Advisory Network on Sex and Gender
It’s good to hear that there will be a review of private prescribing of cross sex hormones for under 18s, but what is long overdue is a review of prescribing to under 18s within the NHS. It i…| Clinical Advisory Network on Sex and Gender
The Australian Doctors Federation urges health professional bodies to reconsider the “gender affirmative treatment” model for youth, citing evidence from reviews like the UK Cass Review…| Clinical Advisory Network on Sex and Gender
This article examines concerns regarding a proposed clinical trial of puberty blockers (PBs) for children with gender dysphoria. It argues that a PB trial would pose unacceptable risks and contrave…| Clinical Advisory Network on Sex and Gender
The World Professional Association for Transgender Health (WPATH) has suppressed evidence that contradicts its policies, influenced by activist clinicians. Unsealed documents reveal WPATH’s e…| Clinical Advisory Network on Sex and Gender
The World Professional Organisation for Transgender Health (WPATH) faces allegations of research malfeasance, prompting concerns about its influence on the World Health Organisation’s (WHO) t…| Clinical Advisory Network on Sex and Gender